Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen

Targeting antigen to dendritic cells (DCs) is a powerful and novel strategy for vaccination. Priming or loading DCs with antigen controls whether subsequent immunity will develop and hence whether effective vaccination can be achieved. The goal of our present work was to increase the potency of DC-b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: Saluja, Sandeep S, Hanlon, Douglas J, Sharp, Fiona A, Hong, Enping, Khalil, David, Robinson, Eve, Tigelaar, Robert, Fahmy, Tarek M, Edelson, Richard L
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2014
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4235494/
https://ncbi.nlm.nih.gov/pubmed/25419128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S66639
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars